BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32209481)

  • 21. Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
    Jones BC; Pohlmann PR; Clarke R; Sengupta S
    Cancer Metastasis Rev; 2022 Jun; 41(2):447-458. PubMed ID: 35419769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APC-Cdh1 Regulates Neuronal Apoptosis Through Modulating Glycolysis and Pentose-Phosphate Pathway After Oxygen-Glucose Deprivation and Reperfusion.
    Li Z; Zhang B; Yao W; Zhang C; Wan L; Zhang Y
    Cell Mol Neurobiol; 2019 Jan; 39(1):123-135. PubMed ID: 30460429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells.
    Cordero-Espinoza L; Hagen T
    J Biol Chem; 2013 Dec; 288(50):36020-8. PubMed ID: 24169697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis.
    Li FL; Liu JP; Bao RX; Yan G; Feng X; Xu YP; Sun YP; Yan W; Ling ZQ; Xiong Y; Guan KL; Yuan HX
    Nat Commun; 2018 Feb; 9(1):508. PubMed ID: 29410405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.
    Yang JG; Wang WM; Xia HF; Yu ZL; Li HM; Ren JG; Chen G; Wang BK; Jia J; Zhang W; Zhao YF
    Int J Cancer; 2019 Sep; 145(5):1358-1370. PubMed ID: 30785217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
    Chesney J
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.
    Ge X; Lyu P; Cao Z; Li J; Guo G; Xia W; Gu Y
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1115-21. PubMed ID: 26093295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional diversity of PFKFB3 splice variants in glioblastomas.
    Heydasch U; Kessler R; Warnke JP; Eschrich K; Scholz N; Bigl M
    PLoS One; 2021; 16(7):e0241092. PubMed ID: 34234350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
    Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
    Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
    Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming.
    Liu J; Liu ZX; Wu QN; Lu YX; Wong CW; Miao L; Wang Y; Wang Z; Jin Y; He MM; Ren C; Wang DS; Chen DL; Pu HY; Feng L; Li B; Xie D; Zeng MS; Huang P; Lin A; Lin D; Xu RH; Ju HQ
    Nat Commun; 2020 Mar; 11(1):1507. PubMed ID: 32198345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
    Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of PFKFB3-driven glycolysis in vessel sprouting.
    De Bock K; Georgiadou M; Schoors S; Kuchnio A; Wong BW; Cantelmo AR; Quaegebeur A; Ghesquière B; Cauwenberghs S; Eelen G; Phng LK; Betz I; Tembuyser B; Brepoels K; Welti J; Geudens I; Segura I; Cruys B; Bifari F; Decimo I; Blanco R; Wyns S; Vangindertael J; Rocha S; Collins RT; Munck S; Daelemans D; Imamura H; Devlieger R; Rider M; Van Veldhoven PP; Schuit F; Bartrons R; Hofkens J; Fraisl P; Telang S; Deberardinis RJ; Schoonjans L; Vinckier S; Chesney J; Gerhardt H; Dewerchin M; Carmeliet P
    Cell; 2013 Aug; 154(3):651-63. PubMed ID: 23911327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Src facilitates tumorigenesis by phosphorylating and activating G6PD.
    Ma H; Zhang F; Zhou L; Cao T; Sun D; Wen S; Zhu J; Xiong Z; Tsau MT; Cheng ML; Hung LM; Zhou Y; Li Q
    Oncogene; 2021 Apr; 40(14):2567-2580. PubMed ID: 33686238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma.
    He B; Pan H; Zheng F; Chen S; Bie Q; Cao J; Zhao R; Liang J; Wei L; Zeng J; Li H; Cui X; Ding Y; Chao W; Xiang T; Cheng Y; Qiu G; Huang S; Tang L; Chang J; Luo D; Yang J; Zhang B
    J Exp Clin Cancer Res; 2022 Feb; 41(1):77. PubMed ID: 35209949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro.
    Yalcin A; Solakoglu TH; Ozcan SC; Guzel S; Peker S; Celikler S; Balaban BD; Sevinc E; Gurpinar Y; Chesney JA
    Biochem Biophys Res Commun; 2017 Mar; 484(3):687-693. PubMed ID: 28161638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential utility of PFKFB3 as a therapeutic target.
    Bartrons R; Rodríguez-García A; Simon-Molas H; Castaño E; Manzano A; Navarro-Sabaté À
    Expert Opin Ther Targets; 2018 Aug; 22(8):659-674. PubMed ID: 29985086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cells.
    Jang JH; Kim DJ; Ham SY; Vo MT; Jeong SY; Choi SH; Park SS; Jeon DY; Lee BJ; Ko BK; Cho WJ; Park JW
    Biochem Biophys Res Commun; 2020 Jan; 521(2):389-394. PubMed ID: 31668919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells.
    Novellasdemunt L; Obach M; Millán-Ariño L; Manzano A; Ventura F; Rosa JL; Jordan A; Navarro-Sabate A; Bartrons R
    Biochem J; 2012 Mar; 442(2):345-56. PubMed ID: 22115192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.